홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Carbonate Monohydrate → HCID 178476555, 화합물

HRID 897628
인쇄

반응식

HRID 897628 반응식
[CH2:1]([CH:8]1[O:12][C:11](=[O:13])[N:10]([C:14]2[CH:19]=[CH:18][C:17](B3[O:24][C:23]([CH3:26])(C)C(C)(C)O3)=[CH:16][CH:15]=2)[CH2:9]1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.I[C:30]1[C:38]2[C:33](=[N:34][CH:35]=[N:36][C:37]=2[NH2:39])[N:32]([C@H:40]2[CH2:45][CH2:44][C@H:43]([N:46]3[CH2:51][CH2:50][N:49]([CH3:52])[CH2:48][CH2:47]3)[CH2:42][CH2:41]2)[N:31]=1.[OH2:53].C(=O)([O-])[O-:55].[Na+].[Na+]>COCCOC.O>[C:23]([OH:55])(=[O:24])[CH3:26].[C:8]([OH:12])(=[O:53])[CH3:1].[NH2:39][C:37]1[N:36]=[CH:35][N:34]=[C:33]2[N:32]([C@H:40]3[CH2:45][CH2:44][C@H:43]([N:46]4[CH2:47][CH2:48][N:49]([CH3:52])[CH2:50][CH2:51]4)[CH2:42][CH2:41]3)[N:31]=[C:30]([C:17]3[CH:16]=[CH:15][C:14]([N:10]4[CH2:9][CH:8]([CH2:1][C:2]5[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=5)[O:12][C:11]4=[O:13])=[CH:19][CH:18]=3)[C:38]=12
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 3

HCID 2735133Sodium Carbonate MonohydrateHCID 223471605-Benzyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazolan-2-oneHCID 178481015HCID 178481015, 화합물

생성물 1

HCID 178476555HCID 178476555, 화합물수율 49.7%

시약·촉매·용매 2

HCID 962Water용매
HCID 8071
1,2-Dimethoxyethane
용매

실험 절차

A mixture of 5-benzyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazolan-2-one (0.110 g, 0.00029 mol), trans-3-iodo-1-[4-(4-methylpiperazino)-cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine (0.080 g, 0.000181 mol), tetrakis-(triphenylphosphine)palladium (0.012 g, 0.000011 mol) and sodium carbonate monohydrate (0.056 g, 0.00045 mol) was heated in a mixture of ethylene glycol dimethyl ether (5 mL) and water (3 mL) at 80° C. for sixteen hours under an atmosphere of nitrogen. The mixture was allowed to cool to ambient temperature and solvents were removed under the reduced pressure. The residue was purified by preparative HPLC (Hypersil C18, 8 μm, 25 cm; 10-60% acetonitrile-0.1M ammonium acetate over 25 min, 21 mL/min) to yield trans-3-(4-{4-amino-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}phenyl)-5-benzyl-1,3-oxazolan-2-one diacetate (0.049 g, 0.000072 mol) as a white solid.

후처리

  1. customsolvents were removed under the reduced pressure
  2. customThe residue was purified by preparative HPLC (Hypersil C18, 8 μm, 25 cm; 10-60% acetonitrile-0.1M ammonium acetate over 25 min, 21 mL/min)

출처 및 근거

ORD 기록
ord-28a66361df5640058bebe2961708ea96
출처 데이터셋
uspto-grants-2005_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06921763B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트